Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Xenotransplantation

Xenotransplantation Home
          Vaccines, Blood & Biologics
          Xenotransplantation
          Information and Recommendations for Physicians Involved in the Co-Culture of Human Embryos with Non-Human Animal CellsXenotransplantation Information and Recommendations for Physicians Involved in the Co-Culture of Human Embryos with Non-Human Animal Cells
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe U.S. Food and Drug Administration (FDA) wants you to know that the co-culture of human embryos with nonhuman animal cells raises health concerns for the recipients of such embryos, the offspring resulting from such embryos, and the general public. The use of nonhuman animal cells, tissues or organs in the treatment of human medical conditions is called xenotransplantation. The United States Public Health Service (USPHS) and the FDA define xenotransplantation as "any procedure that involves the transplantation, implantation, or infusion into a human recipient of either (a) live cells, tissues, or organs from a nonhuman animal source, or (b) human body fluids, cells, tissues, or organs that have had ex vivo contact with live nonhuman animal cells, tissues, or organs."

Co-culture of human embryos with nonhuman animal cells fits the second part of this definition. During co-culturing, human embryos and nonhuman animal cells are maintained together outside the body, in *ex vivo* contact. Thus, the woman into whom the co-cultured embryos are transferred is a recipient of a xenotransplantation product.

A serious concern regarding the clinical use of xenotransplantation is the potential for the transmission of infectious disease from nonhuman animals to humans. Scientists believe that the potential for transmission of an infectious disease from the animal source to a human is of concern either when live nonhuman animal cells, tissues or organs are implanted directly into a human, or when human cells are exposed to live nonhuman animal cells by *ex vivo* contact. Experience with organ allotransplantation has shown that diseases such as human immunodeficiency virus (HIV) infection, Creutzfeldt-Jakob disease, hepatitis B virus infection and hepatitis C virus infection can be transmitted from the human donor to the recipient. Similarly, xenotransplantation poses concerns for infection with recognized, or as yet unrecognized, infectious agents from nonhuman animals. These concerns may extend beyond the recipient to the general public because of the potential for subsequent transmission of an infectious agent to the recipient's contacts and to the general population. Infections originating from animals that have been known to infect and be transmitted from human to human include, for example, HIV and swine influenza.Many viruses exhibit latency, so that the lack of symptoms at the time of the embryo transfer, or in the short term, does not alleviate all concern.

The U.S. Public Health Service has published guidelines on infectious disease issues in xenotransplantation.  These guidelines, as well as FDA guidance documents, can be found at the website http://www.fda.gov/cber/xap/xap.htm, or obtained from FDA.  They recommend, for example, that:

You should inform recipients of xenotransplantation products that they and their intimate contacts should defer from donation of blood and other tissues.
	You should inform patients that they have been treated with a xenotransplantation product and of the risks involved.
	You should archive patient samples, such as blood, to allow future monitoring for potential infections.
	You should follow patients for their lifetimes and counsel them to be alert to any unusual symptoms.
	You should archive samples of the xenotransplantation product. In this case, the nonhuman animal cells used for the co-culture process should be archived.We would be happy to discuss any questions you might have about these recommendations. The nature and level of our concerns may vary depending on the species of nonhuman animal used in the co-culture technique and the source of the culture cells. We plan to have further public discussion of this topic with an appropriate federal advisory committee. At this time, FDA plans to enforce investigational new drug application (IND) requirements for investigations involving further production of embryos co-cultured with live nonhuman animal cells. However, currently it is not our intent to take enforcement action based on the transfer of already existing embryos created by co-culture with live nonhuman animal cells.

Related Information

Human Cells or Tissues Intended for Transplant into a Human Recipient that Have Ex-vivo Contact with Live Non-human Animal Cells, Tissues or Organs Letter - ARCHIVED

                                                                                  Content current as of:
      03/23/2018
              
              
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  XenotransplantationXenotransplantation
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop